IDEXX Laboratories Inc
NASDAQ:IDXX
Intrinsic Value
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. [ Read More ]
The intrinsic value of one IDXX stock under the Base Case scenario is 246.38 USD. Compared to the current market price of 495.55 USD, IDEXX Laboratories Inc is Overvalued by 50%.
Valuation Backtest
IDEXX Laboratories Inc
Run backtest to discover the historical profit from buying and selling IDXX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
IDEXX Laboratories Inc
Current Assets | 1.5B |
Cash & Short-Term Investments | 453.9m |
Receivables | 529.5m |
Other Current Assets | 511.8m |
Non-Current Assets | 1.8B |
Long-Term Investments | 56.2m |
PP&E | 817.7m |
Intangibles | 450.5m |
Other Non-Current Assets | 440.3m |
Current Liabilities | 951.5m |
Accounts Payable | 110.6m |
Accrued Liabilities | 392.2m |
Short-Term Debt | 250m |
Other Current Liabilities | 198.7m |
Non-Current Liabilities | 823.8m |
Long-Term Debt | 622.9m |
Other Non-Current Liabilities | 201m |
Earnings Waterfall
IDEXX Laboratories Inc
Revenue
|
3.7B
USD
|
Cost of Revenue
|
-1.5B
USD
|
Gross Profit
|
2.2B
USD
|
Operating Expenses
|
-1.1B
USD
|
Operating Income
|
1.1B
USD
|
Other Expenses
|
-253.2m
USD
|
Net Income
|
845m
USD
|
Free Cash Flow Analysis
IDEXX Laboratories Inc
IDXX Profitability Score
Profitability Due Diligence
IDEXX Laboratories Inc's profitability score is 75/100. The higher the profitability score, the more profitable the company is.
Score
IDEXX Laboratories Inc's profitability score is 75/100. The higher the profitability score, the more profitable the company is.
IDXX Solvency Score
Solvency Due Diligence
IDEXX Laboratories Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Score
IDEXX Laboratories Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IDXX Price Targets Summary
IDEXX Laboratories Inc
According to Wall Street analysts, the average 1-year price target for IDXX is 616.71 USD with a low forecast of 464.6 USD and a high forecast of 708.75 USD.
Ownership
IDXX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
IDXX Price
IDEXX Laboratories Inc
Average Annual Return | 23.28% |
Standard Deviation of Annual Returns | 49.83% |
Max Drawdown | -54% |
Market Capitalization | 41.1B USD |
Shares Outstanding | 83 933 000 |
Percentage of Shares Shorted | 2.71% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 10,350 full-time employees. The company also offers human medical point-of-care & laboratory diagnostics. Its products include health monitoring, others. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment CAG develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services that are used to manage the health status of livestock and poultry.
Contact
IPO
Employees
Officers
The intrinsic value of one IDXX stock under the Base Case scenario is 246.38 USD.
Compared to the current market price of 495.55 USD, IDEXX Laboratories Inc is Overvalued by 50%.